Wiggin and Dana Represents IsoPlexis in Series C-2 Funding Round
Wiggin and Dana represented its client, IsoPlexis, the leader in single-cell functional proteomics, in raising $20M in its Series C-2 financing led by Northpond Ventures LP.
For more information about IsoPlexisโ expansion plans, please click here.